SIMCERE PHARMA (02096) spent 10.1667 million Hong Kong dollars to repurchase 1.49 million shares on November 18th.
Sinopharm (02096) announced that on November 18, 2024, the company invested 1016.67 million...
SIMCERE PHARMA (02096) announced that on November 18, 2024, the company repurchased 1.49 million shares at a cost of 10.167 million Hong Kong dollars. The repurchase price was between 6.71 and 6.98 Hong Kong dollars per share.
Related Articles
NAND supply tightness may persist until 2028! Citi is bullish on AI demand driving memory chip price increases, reiterates "Buy" rating on SanDisk (SNDK.US).
Down 24% year-to-date! McDonald's Corporation (MCD.US) stock could be headed for its longest weekly losing streak in over 20 years; $8.5 billion new strategy sparks market concerns.
Nebius (NBIS.US) Acquires Israeli Startup Inferize to Double Down on AI Inference Business, Deal Value Could Reach Up to $150 Million
NAND supply tightness may persist until 2028! Citi is bullish on AI demand driving memory chip price increases, reiterates "Buy" rating on SanDisk (SNDK.US).
Down 24% year-to-date! McDonald's Corporation (MCD.US) stock could be headed for its longest weekly losing streak in over 20 years; $8.5 billion new strategy sparks market concerns.
Nebius (NBIS.US) Acquires Israeli Startup Inferize to Double Down on AI Inference Business, Deal Value Could Reach Up to $150 Million
